The tumoral uptake of fluorine-18-deoxyglucose (FDG) is based upon enh
anced glycolysis. Following injection, FDG is phosphorylated and trapp
ed intracellularly, An important mechanism to transport FDG into the t
ransformed cell is based upon the action of glucose transporter protei
ns; furthermore; highly active hexokinase bound to tumor mitochondria
helps to trap FDG into the cell. In addition, enhanced FDG uptake may
be due to relative hypoxia in tumor masses, which activates the anaero
bic glycolytic pathway. In spite of these processes, FDG uptake is rel
atively aspecific since all living cells need glucose; Clinical use is
therefore recommended in carefully selected patients. (C) 1998 Elsevi
er Science Inc.